Block 1 Flashcards
Chromosomal mutation alpha thalassemia
Chromosome 16
Chromosome mutation beta thalassemia
Chromosome 11
Chronic myeloid leukemia mutation
t(9;22) - Philadelphia chromosome
Myelodysplastic disorder mutation
Deletion on chromosome 5 or 7
Myeloproliferative disorders mutation
JAK2 (tyrosine kinase)
B cell chronic lymphocytic leukemia has aberrant expression of ___
CD5 B cells have two digit markers T cells have single digit markers Plasma cells have triple digit markers
Follicular lymphoma mutation
t(14;18) Over expression of Bcl2 behind Ig promoter
Mantle cell lymphoma mutation
t(11;14)
Burkitt’s lymphoma mutation
t(8;14) c-MYC also t(8;22) or t(2;8)
Differentiate Hodgkin or non-Hodgkin lymphoma Age > 60 +/- B symptoms Single, generalized, non-contiguous lymphadenopathy B or T cell proliferation Variable prognosis
Non-Hodgkin
Differentiate Hodgkin or non-Hodgkin lymphoma Age variable Prominent B symptoms Contiguous, rarely generalized lymphadenopathy Reed-Sternburg, reactive cells Good prognosis
Hodgkin lymphoma
MC leukemia >60 yo Asymptomatic Lymphocytes, spleen, and LN Autoimmune hemolytic anemia Small, round lymphocytes, diffuse growth, proliferation centers. Smudge cells CD19+, CD20+, CD5+, CD23+ FMC7- Deletions or trisomies Indolent course
B cell lymphoma CLL or SLL
Generalized lymphadenopathy +/- B symptoms Follicular growth, mixed small and large cells Bone marrow paratrabaecular lymphoid aggregate CD19+, CD0+, CD10+ Germinal centers are Bcl2+ t(14;18) Bcl2 Indolent course
Follicular lymphoma
Chronic inflammation tissue mass Gastric (H. Pylori), thyroid (Hashimoto’s), eye, lung Epithelial destruction Gastric, diffuse infiltration by lymphocytes CD19+, CD20+ CD5-, CD10- t(11,18), resistant to antibiotics
Extranodal Marginal Zone Lymphoma (MALToma)
Splenomegaly, bone marrow fibrosis-dry tap, cytopenia Hairy cells Fried egg Myelofibrosis CD19+, CD20+, CD11c+, CD25+, CD103+ Tartrate resistant acid phosphatase (TRAP) BRAF mt Indolent course
Hairy cell leukemia
Waldenstrom Macroglobulinemia - IgM monoclonal protein - hyper-viscosity, vision, neuro, bleeding, cryoglobulin (Raynaud’s), lymphadenopathy, splenomegaly Lymphocytes and plasma cells Rouleux RBCs IgM serum protein CD19+ and CD20+ lymphocytes CD138+ plasma cells Indolent course
Lymphoplasmacytic lymphoma
Enlarging node/mass, B symptoms, de novo or transformation form low grade Common in HIV+, especially in brain Diffuse growth, large cells CD19+, CD20+, CD10 +/- Ki67 proliferation marker Aggressive course
Diffuse large B cell lymphoma
Enlarging node/mass (terminal ileum) B symptoms Endemic in jaw in Africa, 100% EBV Sporadic HIV+ Diffuse growth Starry sky (apoptosis) Basophilic cytoplasm vacuoles CD19-, CD20+, CD10+ Ki67+ proliferation marker t(8;14) c-MYC Aggressive course
Burkitt lymphoma
Lymphadenopathy, splenomegaly, GI tract, B symptoms Diffuse growth Cleaved cells CD19+, CD20+, CD5+, FMC7+ CD23- Cyclin D1 + t(11;14) cyclinD1 Promotes progression through the cell cycle Aggressive course
Mantle cell lymphoma
CRAB Calcium elevation Renal complications Anemia Bone disease Elderly, 2x blacks Increased infections Urine Bence-Jones protein Amyloidosis- Congo red stain, Apple green birefringence Lyric, punched-out lesions Hyper-viscosity- headaches, fatigue, bruising, GI bleeding, vision abnormalities just as retinopathy IgG >3g/dL (serum M spike) Plasma cells > 20-30% in bone marrow CD19-, CD20- CD138+ Cytoplasmic light chain Translocations, gains or deletions Progressive course
Plasma cell myeloma
Asymptomatic, labs negative IgG < 3g/dL Plasma cells < 10% 1% per year —> myeloma
Monoclonal gammopathy of unknown significance (MGUS)
Leukocytosis, lymphadenopathy, splenomegaly, hypercalcemia, rash HTLV1+ Japan, Caribbean, Africa -mycoses fungoides -Sezary syndrome Lymphocytosis Clover leaf, flower cell CD3+, CD4+ Reverse transcriptase + Aggressive
Adult T cell leukemia/lymphoma
Abdominal pain, weight loss, diarrhea, obstruction, celiac disease Small intestine, intraepithelial T cells Villous atrophy, ulcer, mass CD3+ Aggressive
Enteropathy associated T cell Lymphoma
Lymphadenopathy, extranodal sites Adult and children Large pleomorphic cells (hallmark cells) CD30+, ALK+, CD15- t(2;5) Good prognosis unless ALK-
Anaplastic large cell lymphoma
Destructive mass, commonly nasopharyngeal EBV associated Asia Destruction of blood vessels, necrosis CD3+, CD8+ T cells CD56+ NK cells Aggressive course
Extranodal NK/T cell lymphoma
Cutaneous lesions, patches, plaques, nodules Epidermotropism Pautrier’s microabscesses Cerebriform nuclei CD3+, CD4+ Indolent course Palliative treatment but not curative
Mycoses fungoides
Aggressive systemic variant of cutaneous T cell lymphoma Generalized erythroderma Lymphadenopathy Leukocytosis Cerebriform nuclei
Sezary syndrome
Unifocal- adults, lytic bone lesion Multifocal- children, multiple lytic lesions, skin, hepatosplenomegaly Oval cells, grooved cells Birbeck granules on electron microscopy CD1a+ S100+
Langerhans cell histiocytosis
Differentiate Classical Hodgkin’s (CHL) and Nodular Lymphocyte Predominant Hodgkin (NLPH) Age variable Single or contiguous LN Classical, lacunar, mononuclear cell type CD30+, CD15+ CD20- EBV+/- Good prognosis
CHL Includes: Nodular sclerosis Hodgkin lymphoma Mixed cellularity Hodgkin lymphoma Lymphocyte depleted Hodgkin lymphoma Lymphocyte rich Hodgkin lymphoma
Differentiate Classical Hodgkin’s (CHL) and Nodular Lymphocyte Predominant Hodgkin (NLPH) Male <35yo Single LN Nodular, RS cell Popcorn cells Background cells- lymphocytes CD20+ CD30-, CD15- EBV- Very good prognosis
NLPH
70% of all CHL Young patients Mediastinal +/- B symptoms Broad collagen bands Nodules Classic RS cell, lacunar cells Background cells: eosinophils, neutrophils, lymphocytes CD30+, CD15+ CD20- EBV+
Nodular sclerosis Hodgkin lymphoma
CHL Older patients B symptoms No fibrosis Classic RS cells Background cells: eosinophils, neutrophils, lymphocytes CD30+, CD15+ CD20- EBV ++
Mixed cellularity Hodgkin lymphoma
CHL Older adults HIV+ Developing countries No fibrosis Classic RS cells Background cells: histiocytes and fibroblasts CD30+, CD15+ CD20- EBV+
Lymphocyte depleted Hodgkin lymphoma
CHL rare Young patients usually no B symptoms Nodular growth Classic RS cells Background cells: lymphocytes CD30+, CD15+ CD20- EBV+ infrequent
Lymphocyte rich Hodgkin lymphoma
Splenectomy increases risk of infection with ___ bacteria
Encapsulated
Epithelial neoplasm of the thymus Lymphocytes are non neoplastic Adults with SOB and a mediastinal mass Paraneoplastic syndrome Myasthenia gravis Pure red cell aplasia Graves, pernicious anemia, dermatomyositis Tx: resection Invasion decreases outcome
Thymoma
Identify the disease
Iron deficiency anemia
Hypochromic and microcytic RBCs
Identify the disease
Anemia of chronic disease
Increased Ferritin
Decreased serum iron
Decreased transferrin
Decreased % saturation
Decreased TIBC
Increased FEP
Identify the disease
Sideroblastic anemia
Identify the diseases (2)
Target cells
EITHER:
sickle cell anemia (normocytic, extravascular hemolysis)
B thalassemia (microcytic)
Identify the diseases (2)
Expanded hematopoiesis
EITHER:
sickle cell anemia (normocytic, extravascular hemolysis)
B thalassemia (microcytic)
Identify the diseases (2)
Megaloblastic anemia
Either: B12 or folate deficiency
Enlarged RBCs and WBCs, including neutrophils which appear as hypersegmented
Identify the cell type
Appears in ___ anemias
Reticulocytes
Normocytic anemias
Identify the disease
Hereditary spherocytosis
Extravascular hemolysis and normocytic anemia
Identify the disease
Sickle cell anemia
Extravascular hemolysis and normocytic anemia
Identify the disease
Hemoglobin C
HbC crystals in RBCs
Extravascular hemolysis and normocytic anemia
Identify the substance present in this slide
Hemosiderin
Iron storage not readily available
Identify the disease
G6PD
Heinz bodies and Bite cells
Identify the disease
Immuno hemolytic anemia (IHA)
RBC agglutination, can be due to IgG or IgM
Identify the disease
Microangiopathic hemolytic anemia
Schistocytes and Helmet cells
Identify the disease
Aplastic anemia
Bone marrow is replaced by fat cells
Normocytic anemia with decreased production of RBCs
Differentiating leukemoid reaction from CML
Leukemoid reaction:
Asymptomatic or symptomatic?
Present/not toxic granulation?
Present/not basophils?
Present/not increased alkaline phosphatase?
Present/not altered genetics?
Symptomatic
Present toxic granulation
Absent basophils
High LAP
Normal genetics
Identify the disease
Leukemoid Reaction
Band cells
high LAP
ABSENT BASOPHILS (CML)
Identify the disease
CML
PRESENT BASOPHILS
Increased blast cells (left shift)
Low LAP
t(9;22)
Infectious Mono or B cell lymphoma (CLL/SLL)?
young patient
Fever, pharyngitis, LN and splenomegaly
Acute
Atypical lymphocytes
Positive Monospot/EBV
Normal flow cytometry
Self-limiting
Infectious mononucleosis
Identify the disease
Infectious mononucleosis
Atypical but BENIGN lymphocytes
Identify the disease
B cell lymphoma (CLL/SLL)
small lymphocytes with condensed chromatin and scant cytoplasm
Smudge cells